Sreyashi Basu

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial”.

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(21)00427-1

N/A

4.7DataRank · unranked

263 citations

Elshad Hasanov, Hop Sanderson Tran Cao, Lianchun Xiao, Jean‐Nicolas Vauthey, Sunyoung S. Lee +24 more

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Nature Medicine(2023)10.1038/s41591-022-02189-0

N/A

4.1DataRank · unranked

213 citations

Cheuk Hong Leung, Annikka Weissferdt, Apar Pataer, Brett W. Carter, Myrna C. B. Godoy +52 more

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer

Nature Communications(2021)10.1038/s41467-021-25188-0

N/A

3.1DataRank · unranked

110 citations

Annikka Weissferdt, Myrna C. B. Godoy, William N. William, Cheuk Hong Leung, Heather Lin +23 more

Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002919

N/A

1.6DataRank · unranked

56 citations

Bilal A. Siddiqui, Ana M. Aparicio, Shalini S. Yadav, Sreyashi Basu, Hong Chen +8 more

Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy

Nature Communications(2021)10.1038/s41467-021-26282-z

N/A

0.734DataRank · unranked

132 citations

Dapeng Hao, Katarzyna Tomczak, Praveen Barrodia, Jin S. Im, Patrick K. Reville +28 more

Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006262

N/A

0.449DataRank · unranked

19 citations

Brian F. Chapin, Sonali Jindal, Fei Duan, Sreyashi Basu, Shalini S. Yadav +16 more

EON: Phase II trial of etigilimab (MPH313) in combination with nivolumab in patients with recurrent platinum-resistant clear cell ovarian cancer.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5573

N/A

0.104DataRank · unranked

1 citations

Emily Hinchcliff, Shuqi Wang, Amir A. Jazaeri, Anil K. Sood, Bryan Fellman +14 more

Multimodal spatial proteomic profiling in acute myeloid leukemia

npj Precision Oncology(2025)10.1038/s41698-025-00897-7

N/A

0DataRank · unranked

10 citations

Ivo Veletić, Christopher D. Pacheco, Enes Dasdemir, Fatima Zahra Jelloul, Sammy Ferri‐Borgogno +15 more

Single-cell Characterization of Acute Myeloid Leukemia and its Microenvironment Following PD-1 Blockade Based Therapy

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.03.278309

N/A

0DataRank · unranked

3 citations

Dapeng Hao, Katarzyna Tomczak, Praveen Barrodia, Jin S. Im, Patrick K. Reville +22 more

Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence

Kidney International Reports(2025)10.1016/j.ekir.2025.10.018

N/A

0DataRank · unranked

0 citations

Masroor Habeeb, Hong Chen, Zainab Alhamal, Omar Mamlouk, Heather Lin +7 more

Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by IL-6 blockade

Research Square(2023)10.21203/rs.3.rs-3161761/v1

N/A

0DataRank · unranked

10 citations

Erez N. Baruch, Priyadahrshini Nagarajan, Frederico O. Gleber‐Netto, Xiayu Rao, Tongxin Xie +34 more

Investigative needle core biopsies for multi-omics in Glioblastoma

medRxiv(2023)10.1101/2023.12.29.23300541

N/A

0DataRank · unranked

6 citations

Sreyashi Basu, Gerard Baquer, Ryuhjin Ahn, Jennifer Gantchev, Sonali Jindal +44 more

TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer

Nature Communications(2024)10.1038/s41467-024-49189-x

N/A

0DataRank · unranked

19 citations

Shelley M. Herbrich, Sangeeta Goswami, Baoxiang Guan, Yulong Chen, Marc Macaluso +12 more

Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis

Cancer Immunology Research(2024)10.1158/2326-6066.cir-24-0011

N/A

0DataRank · unranked

15 citations

Nicolas L. Palaskas, Sreyashi Basu, Yibo Dai, Zhong He, Shalini S. Yadav +12 more

Investigative needle core biopsies support multimodal deep-data generation in glioblastoma

Nature Communications(2025)10.1038/s41467-025-58452-8

N/A

0DataRank · unranked

16 citations

Sreyashi Basu, Gerard Baquer, Ryuhjin Ahn, Jennifer Gantchev, Sonali Jindal +71 more

Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trial

Nature Communications(2025)10.1038/s41467-025-57009-z

N/A

0DataRank · unranked

14 citations

Jianjun Gao, Sreyashi Basu, Daniel D. Shapiro, José A. Karam, Rebecca S. Tidwell +22 more